New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.
These molecules not only rapidly improve symptoms, but remarkably, also appear to renew the underlying brain impairments causing memory loss in preclinical models. These findings were presented today at the American Association for the Advancement of Science (AAAS) Annual Meeting in Washington DC.
“Currently there are no medications to treat cognitive symptoms such as memory loss that occur in depression, other mental illnesses and aging,” says Dr. Etienne Sibille, Deputy Director of the Campbell Family Mental Health Research Institute at CAMH and lead scientist on the study.
What’s unique and promising about these findings, in the face of many failures in drug development for mental illness, is that the compounds are highly targeted to activate the impaired brain receptors that are causing memory loss, he says.
It took a series of studies – the most recent appearing in January 2019 in Molecular Neuropsychiatry – to reach this stage. First, Dr. Sibille and his team identified the specific impairments to brain cell receptors in the GABA neurotransmitter system. Then they showed that these impairments likely caused mood and memory symptoms in depression and in aging.
The new small molecules were invented to bind to and activate this receptor target. The idea was that they would exert a therapeutic effect by “fixing” the impairment, resulting in an improvement in symptoms. The molecules are chemical tweaks of benzodiazepines, a class of anti-anxiety and sedative medications that also activate the GABA system, but are not highly targeted.
A single dose of these new molecules was administered in preclinical models of stress-induced memory loss. Thirty minutes later, memory performance returned to normal levels, an experiment that was reproduced more than 15 times. In another experiment involving preclinical models of aging, memory declines were rapidly reversed and performance increased to 80 per cent after administration, essentially reaching levels seen in youth or earlier stages of adulthood. This improvement lasted over two months with daily treatment.
“The aged cells regrew to appear the same as young brain cells, showing that our novel molecules can modify the brain in addition to improving symptoms,” says Dr. Sibille. He expects to start testing the molecules in clinical research in two years. “We’ve shown that our molecules enter the brain, are safe, activate the target cells and reverse the cognitive deficit of memory loss.”
If successful, the potential applications are broad. Not only is there a lack of treatment for cognitive deficits in mental illness, but the brain improvements suggest the molecules could help to prevent the memory loss at the beginning of Alzheimer’s disease, potentially delaying its onset.
Learn more: New molecules reverse memory loss linked to depression, aging
The Latest on: Memory loss and depression
[google_news title=”” keyword=”memory loss and depression” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Memory loss and depression
- ‘She was 16 and he was 61’’: This TikTok trend will have you questioning your grandparents’ marriageon April 25, 2024 at 2:44 pm
For many of our grandmothers, great-grandmothers and the generations before, marriage may not have been a union of love, but rather a means of surviving oppression.
- Researchers say 3p tablet can make you 'happier', reduce anxiety and tackle tirednesson April 25, 2024 at 5:51 am
If you find yourself struggling with anxiety, tiredness and a low mood, if might be because you are lacking vitamin B12 ...
- Severity of Resistant Depression Predicts Ketamine vs ECT Responseon April 24, 2024 at 7:17 am
The severity of TRD appeared to predict response to IV ketamine vs ECT. However, experts said more research is needed before drawing any definitive conclusions.
- Alzheimer’s Association to present free webinar for caregivers and health professionalson April 24, 2024 at 5:36 am
Reflections and Healing" presentation is aimed at helping caregivers and health professionals manage ongoing grief and loss ...
- Mental Health Matters: A conversation about love, loss, and a walk of hopeon April 23, 2024 at 12:50 pm
Marie Mortera previews the 'Out of the Darkness Walk' hosted by the Nevada chapter of the American Foundation for Suicide Prevention. Here's her conversation wi ...
- Long-term stress may lead to memory loss, neurologists warnon April 22, 2024 at 7:01 pm
Neurologists have warned that prolonged exposure to stress can heighten the chances of experiencing anxiety and depression, which in turn raises the risk of memory loss.They explained that during ...
- Recognizing the signs: When a loved one needs memory supporton April 22, 2024 at 4:04 am
Struggling to perform once routine tasks can be a warning sign that a loved one is experiencing memory loss. The Mayo Clinic advises that difficulty with tasks an older adult has performed for years, ...
- Lewy body dementia – signs, symptoms and treatmenton April 19, 2024 at 12:00 am
For years, Des O’Sullivan struggled to pinpoint what felt wrong. When his symptoms started, Des was in his early 50s, a busy publishing consultant whose career rested on meeting budgets and deadlines.
- The Echoes of Memory Laneon April 12, 2024 at 10:37 am
It’s been a pretty long-held belief that older people become senile, but losing the ability to function and do the things that are important to you — that’s not a normal part of aging,” he says.
- This vitamin deficiency can cause forgetfulness and mimic symptoms of dementia—but it’s reversible. Doctors explain the signs to look foron April 11, 2024 at 12:32 am
People with vitamin B12 deficiency may act forgetful and confused, and struggle with concentrating and accomplishing tasks, Kaiser says. In more severe vitamin B12 deficiencies, a person may develop ...
via Bing News